Zobrazeno 1 - 10
of 708
pro vyhledávání: '"Hepburn T"'
Autor:
Hull, M.A., Sprange, K., Hepburn, T., Tan, W., Shafayat, A., Rees, C.J., Clifford, G., Logan, R.F., Loadman, Paul, Williams, E.A., Whitham, D., Montgomery, A.A.
Yes
Background: The omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) and aspirin both have proof of concept for colorectal cancer chemoprevention, aligned with an excellent safety profile. Therefore, we aimed to test the efficacy o
Background: The omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) and aspirin both have proof of concept for colorectal cancer chemoprevention, aligned with an excellent safety profile. Therefore, we aimed to test the efficacy o
Externí odkaz:
http://hdl.handle.net/10454/16687
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Desborough MJR; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Radcliffe Department of Medicine, University of Oxford, Oxford, UK. Electronic address: michael.desborough@ouh.nhs.uk., Al-Shahi Salman R; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK., Stanworth SJ; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Radcliffe Department of Medicine, University of Oxford, Oxford, UK; Transfusion Medicine, NHS Blood and Transplant, Oxford, UK., Havard D; Stroke Trials Unit, University of Nottingham, Nottingham, UK., Woodhouse LJ; Stroke Trials Unit, University of Nottingham, Nottingham, UK., Craig J; Stroke Trials Unit, University of Nottingham, Nottingham, UK., Krishnan K; Stroke, Medicine Division, Nottingham University Hospitals NHS Trust, Nottingham, UK., Brennan PM; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK., Dineen RA; Radiological Sciences, University of Nottingham, Nottingham, UK; NIHR Nottingham Biomedical Research Centre, Nottingham, UK., Coats TJ; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK., Hepburn T; Mental Health and Clinical Neurosciences, and Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK., Bath PM; Stroke Trials Unit, University of Nottingham, Nottingham, UK; Stroke, Medicine Division, Nottingham University Hospitals NHS Trust, Nottingham, UK., Sprigg N; Stroke Trials Unit, University of Nottingham, Nottingham, UK; Stroke, Medicine Division, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Publikováno v:
The Lancet. Neurology [Lancet Neurol] 2023 Jul; Vol. 22 (7), pp. 557-567.
Autor:
Armstrong-Buisseret L; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK., Brittain C; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK., Kai J; Division of Primary Care, School of Medicine, University of Nottingham, Nottingham, UK., David M; Clinical Microbiology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Anstey Watkins J; Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK., Ozolins M; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK., Jackson L; Health Economics Unit, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Abdali Z; Health Economics Unit, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Hepburn T; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK., Griffiths F; Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.; Centre for Health Policy, University of the Witwatersrand, Johannesburg, South Africa., Montgomery A; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK., Daniels J; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK., Manley A; Department of Genitourinary Medicine, Whittall Street Clinic, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Dean G; Elton John Research Centre, Brighton, UK., Ross JD; Department of Genitourinary Medicine, Whittall Street Clinic, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Publikováno v:
Health technology assessment (Winchester, England) [Health Technol Assess] 2022 Jan; Vol. 26 (2), pp. 1-170.
Autor:
Herbison, N., Cobb, S., Gregson, R., Ash, I., Eastgate, R., Purdy, J., Hepburn, T., MacKeith, D., Foss, A., I. BiT study group
PURPOSE: A computer-based interactive binocular treatment system (I-BiT) for amblyopia has been developed, which utilises commercially available 3D 'shutter glasses'. The purpose of this pilot study was to report the effect of treatment on visual acu
Externí odkaz:
http://hdl.handle.net/10454/9578
Autor:
Bath, PM, Woodhouse, LJ, Krishnan, K, Appleton, JP, Anderson, CS, Berge, E, Cala, L, Dixon, M, England, TJ, Godolphin, PJ, Hepburn, T, Mair, G, Montgomery, AA, Phillips, SJ, Potter, J, Price, CI, Randall, M, Robinson, TG, Roffe, C, Rothwell, PM, Sandset, EC, Sanossian, N, Saver, JL, Siriwardena, AN, Venables, G, Wardlaw, JM, Sprigg, N
Publikováno v:
Bath, P M, Woodhouse, L J, Krishnan, K, Appleton, J P, Anderson, C S, Berge, E, Cala, L, Dixon, M, England, T J, Godolphin, P J, Hepburn, T, Mair, G, Montgomery, A A, Phillips, S J, Potter, J, Price, C I, Randall, M, Robinson, T G, Roffe, C, Rothwell, P M, Sandset, E C, Sanossian, N, Saver, J L, Siriwardena, A N, Venables, G, Wardlaw, J M & Sprigg, N 2019, ' Prehospital Transdermal Glyceryl Trinitrate for Ultra-Acute Intracerebral Hemorrhage : Data From the RIGHT-2 Trial ', Stroke . https://doi.org/10.1161/STROKEAHA.119.026389
Background and Purpose- Pilot trials suggest that glyceryl trinitrate (GTN; nitroglycerin) may improve outcome when administered early after stroke onset. Methods- We undertook a multicentre, paramedic-delivered, ambulance-based, prospective randomiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ae4bd4c003b46426fe7182f9358ec2d9
https://ueaeprints.uea.ac.uk/id/eprint/72711/
https://ueaeprints.uea.ac.uk/id/eprint/72711/
Autor:
Haydock R; Nottingham Clinical Trials Unit (NCTU), Applied Health Research Building, University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Hepburn T; Nottingham Clinical Trials Unit (NCTU), Applied Health Research Building, University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Ross J; Department of GU Medicine, University Hospitals Birmingham NHS Foundation Trust, Whittall Street Clinic, Whittall Street, Birmingham, B4 6DH, UK., Daniels J; Nottingham Clinical Trials Unit (NCTU), Applied Health Research Building, University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Brittain C; Nottingham Clinical Trials Unit (NCTU), Applied Health Research Building, University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Jackson L; Health Economics Unit, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK., Ozolins M; Nottingham Clinical Trials Unit (NCTU), Applied Health Research Building, University of Nottingham, University Park, Nottingham, NG7 2RD, UK., Wilson J; GU Medicine Service, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Great George Street, Leeds, LS1 3EX, UK. janet-d.wilson@nhs.net.
Publikováno v:
Trials [Trials] 2022 Dec 21; Vol. 23 (1), pp. 1040. Date of Electronic Publication: 2022 Dec 21.
Autor:
Haines RH; Nottingham Clinical Trials Unit, School of Medicine, University of Nottingham, Nottingham, UK., Hepburn T; Nottingham Clinical Trials Unit, School of Medicine, University of Nottingham, Nottingham, UK., Tan W; Nottingham Clinical Trials Unit, School of Medicine, University of Nottingham, Nottingham, UK., Jackson C; School of Medicine, University of Nottingham, Nottingham, UK., Lathe J; Nottingham Clinical Trials Unit, School of Medicine, University of Nottingham, Nottingham, UK., White J; Nottingham Clinical Trials Unit, School of Medicine, University of Nottingham, Nottingham, UK., Almey C; PPI Representative, National Institute for Health and Care Research Nottingham Biomedical Research Centre, Nottingham, UK., Nicholson R; Nottingham University Hospitals NHS Trust, Nottingham, UK., Stockdale D; British Tinnitus Association, Sheffield, UK., Leighton P; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK., James M; Nottingham Clinical Trials Unit, School of Medicine, University of Nottingham, Nottingham, UK., Sereda M; National Institute for Health and Care Research Nottingham Biomedical Research Centre, Nottingham, UK. Magdalena.sereda@nottingham.ac.uk.; Hearing Sciences, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, UK. Magdalena.sereda@nottingham.ac.uk.
Publikováno v:
Pilot and feasibility studies [Pilot Feasibility Stud] 2022 Nov 03; Vol. 8 (1), pp. 235. Date of Electronic Publication: 2022 Nov 03.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Desborough, M, Salman, R, Stanworth, S, Havard, D, Brennan, P, Dineen, R, Coats, T, Johnson, P, Hepburn, T, Bath, P, Sprigg, N, investigators, DASH trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::355f9884e493f184cead1de2c32d4b99
https://doi.org/10.1111/bjh.15854
https://doi.org/10.1111/bjh.15854